Market Place
Sourcing Support
Stock Recap #PipelineProspector
Pipeline Prospector 2023 highlights: Obesity drugs perk up Lilly, Novo sales; ADCs spur dealmaking
The year 2023 was marked by volatility. The good news is that despite factors like inflation, intere
Pipeline Prospector Oct 2023: Disappointing Q3 results, attacks on Israel, Gaza drag pharma indices down further
October was a gloomy month that saw Palestinian militant group Hamas attack Israel in the first week
Pipeline Prospector March 2023: Silicon Valley Bank collapse hits biotech indices; Pfizer buys out Seagen
Biotech indices have witnessed a lot of volatility throughout 2022 and 2023. Just when they were beg
Pipeline Prospector Jan 2023: Mega cap drugmakers face rout at bourses even as biotech indices inch upwards
After facing the worst year since 2008, biotech indices opened 2023 on a positive note. All the thre
Pipeline Prospector Feb 2022: Biotechs face cash crunch after stock market ‘bloodbath’
Our January 2022 update of the Pipeline Prospector highlighted how the Omicron variant of the novel
